Dicon Tablet

About Dicon 5 mg Tablet

Made by Jayson Pharmaceuticals Ltd., Dicon is a tablet whose active ingredient is Glibenclamide. It is not meant for insulin-dependent diabetes or for people who have had their pancreas removed.

There are 14 brands of Glibenclamide listed in Bangladesh. 5 of them have a lower unit price than Dicon.

What is Dicon 5 mg Tablet?

Dicon is a tablet from Jayson Pharmaceuticals Ltd., with the generic name Glibenclamide. It is used for non-insulin-dependent diabetes mellitus, a type where the body still produces some insulin. It is not effective in patients whose pancreas cannot produce insulin, such as those with juvenile-onset diabetes or in completely pancreatectomized patients. The doctor decides if this medicine is suitable.

Uses of Dicon

It is not meant for insulin-dependent diabetes or for people who have had their pancreas removed. This medicine is not suitable for people with completely removed pancreas or juvenile-onset diabetes, as it cannot work without some insulin production. It should be used as part of a overall diabetes management plan, including weight reduction and dietary changes. Ask your doctor whether it is right for your condition.

How to use Dicon

Your doctor may check your blood and urine sugar regularly and adjust your dose. Swallow the tablet with water. Dicon is taken by mouth. Take Dicon 5 mg tablet by mouth as your doctor tells you. The dose and course are decided by your doctor based on your blood sugar levels and response. Always follow the doctor's instructions and do not take more than prescribed.

Side effects of Dicon

If you notice any unusual symptoms, especially signs of low blood sugar, contact your doctor promptly. Some people may experience nausea, vomiting, stomach pain, dizziness, weakness, tingling, or headache. If you experience any side effects, contact your doctor. Contact your doctor if you notice anything unusual after taking it. Tell your doctor if any side effect bothers you or does not go away.

Safety and precautions

Dicon 5 mg tablet is contraindicated in severe metabolic decompensation with acidosis, pre-comatose states, diabetic coma, severe renal or hepatic dysfunction, serious impairment of thyroid or adrenal function, pregnancy, and diabetes complicated by fever, trauma, or gangrene. Discuss with your doctor if you have other health conditions or take other medicines. Weight reduction is an important part of diabetes treatment and should be discussed with your doctor. Tell your doctor if you are pregnant, planning pregnancy, or breastfeeding, as there is limited information on its use in human pregnancy and it may pass into breast milk.

Frequently asked questions

What does Dicon treat?

It is not meant for insulin-dependent diabetes or for people who have had their pancreas removed. This medicine is not suitable for people with completely removed pancreas or juvenile-onset diabetes, as it cannot work without some insulin production.

How is Dicon used?

Your doctor may check your blood and urine sugar regularly and adjust your dose. Swallow the tablet with water.

Can Dicon cause side effects?

If you notice any unusual symptoms, especially signs of low blood sugar, contact your doctor promptly. Some people may experience nausea, vomiting, stomach pain, dizziness, weakness, tingling, or headache.

How much does Dicon cost in Bangladesh?

The listed price is ৳ 0.28.

Indications

Glibenclamide is used in the treatment of non insulin dependent diabetes melitus (NIDDM). It is ineffective in completely pancreatectomized patients and in juvenile-onset type of diabetes, in which the pancreas has lost all or nearly all of its capacity to secrete insulin. Such patients require insulin and attempts to control them with oral therapy are dangerous and doomed to failure.

Pharmacology

Glibenclamide is an orally effective hypoglycaemic agent that reduces blood sugar concentration by stimulating secretion of endogenous insulin from the pancreatic β-cells. It stimulates the mobilization of endogenous insulin with a lower dosage and with few incidence of side effects that any available anti-diabetic. Hypoglycaemic action associated with short-term therapy appears to include reduction of basal hepatic glucose production and enhancement of peripheral insulin action at target sites.

Dosage & Administration

Initially stabilization dosage: Glibenclamide half tablet (2.5 mg) should be taken initially during or immediately after breakfast. 3-5 days after initiation of the drug, the blood sugar level and urine sugar level should be checked. Daily dose of ½ tablet (2.5 mg) may be continued as maintenance therapy if good control has been achieved. If the result is not good, increment of daily dose in steps of ½ tablet (2.5 mg) is necessary at intervals of 3-5 days up to a maximum of 3 tablets. Daily doses in excess of 10 mg may be taken in 2 divided doses. Patients should be given ½ to 1 tablet of Glibenclamide in changing over from other oral anti-diabetics with a similar action.

Change over from insulin to Glibenclamide: The mildly diabetic patient whose insulin requirement is fewer than 20 units daily, can be started on the initial dosage of Glibenclamide with immediate discontinuation of insulin. If the insulin requirement is moderate or high, the changeover should be made gradually by giving insulin and Glibenclamide simultaneously and slowly cutting down the dose of insulin.

When insulin requirements are increased as in fever, surgical interventions or trauma, the Glibenclamide alone is inadequate and the patient must be given insulin to carry him or her through such critical situation.

This changeover from insulin to Glibenclamide is strictly for NIDDM of fairly recent onset which is being controlled on small doses of insulin. This should preferably be done in hospital or with daily medical supervision.

Interaction

Alcohol, cyclophosphamide, dicoumarol, monoamino oxidase inhibitors, phenylbutazone, propranolol and other beta-adrenergic blocking agents and certain long-acting sulphonamides may enhance the hypoglycemic effect of Glibenclamide

Contraindications

Severe metabolic de-compensation with acidosis, pre-comatose states and diabetic coma, severe renal or hepatic dysfunction or serious impairment of typhoid or adrenal function; pregnancy, diabetes mellitus complicated by fever, trauma or gangrene.

Side Effects

Glibenclamide is well tolerated. Few side effects that may arise include nausea, vomiting, epigastric pain, dizziness, weakness, paraesthesia and headache. Allergic skin reactions and haemopoietic reactions (leukopenia, thrombocytopenia, etc.) are occasionally observed.

Pregnancy & Lactation

There is no information on the use of Glibenclamide in human pregnancy but it has been in wide, general use for many years without apparent ill consequence. Animal studies have shown no hazard. It has not yet been established whether Glibenclamide is transferred to human milk. However, other sulphonylureas have been found in milk and there is no evidence to suggest that Glibenclamide differs from the group in this respect.

Precautions & Warnings

Weight reduction is of the greatest importance in the treatment of diabetes. A vigorous effort must be made by the patient and the physician to reduce the patient's weight as an integral part of diabetic treatment, irrespective of the drug chosen.

Overdose Effects

Symptoms: Hypoglycaemia.

Management: Mild hypoglycaemic symptoms without loss of consciousness or neurologic findings may be treated with oral glucose and adjust drug dosage and/or meal patterns.

Storage Conditions

Should be stored in a dry place below 30˚ C.

Alternative brands of Glibenclamide

Other brands with the same generic name, cheapest first.

See all 14 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.